The long process of revision of EU GMP Annex 1 for the manufacture of sterile medicinal products is approaching the end.  Join us for an in-depth analysis of the key points with the involvement of Annex 1 experts, opinion leaders, and regulatory body representatives.

Featuring:

• ANNEX 1 revision: impact of key points and regulatory expectations
• Environmental monitoring: compliance & innovative technologies 
• Sterilization: compliance & future perspectives
• Personnel & aseptic process simulation: best practices
• Interactive exhibition on innovative technologies
• Innovative technologies in sterile manufacturing controls
• Inspection trends in sterile manufacturing
• Design and implementation of the contamination control strategy: a case study 
• Innovative technologies in containment systems
• Overcoming technical challenges in decontamination processes and material transfers
• Pharma 4.0: Innovations and advanced aseptic manufacturing technologies